JPRN-C000000278已完成未知
eoadjuvant chemotherapy using the TXL and CDDP followed by surgery for advanced gastric cancer - Phase II - TC-NAC-P2
TC therapy for gastric cancer study group0 个研究点目标入组 50 人开始时间: 2005年11月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Serious complications 2) Active multiple cancer 3) Obvious infection or acute inflammatory condition 4) Under treatment with systemic steroid 5) Probable pregnancy, and the period of lactation 6) Difficulty to join the trial due to psychosis or psychotic symptoms 7) Allergy to drugs containing Cremophor EL (including cyclosporin) 8) History of severe drug allergic reaction 9) History of alcoholic allergic reaction 10) Peripheral neuropathy 11) Not fit to the protocol treatment by the physicion's dicision
研究者
相似试验
进行中（未招募）
1 期
eoadjuvant, sequential chemotherapy with docetaxel followed by Fluorouracil, Epirubicin, and Cyclophosphamid every 3 weeks - genome wide expression analysis for identification of a predictive gene signature in patients with primary breast cancer - EXPRESSIOEligible will be only females between 18 - 70 years of age, suffering from histologically confirmed primary breast cancer, nodal status positive or negative, phase cT2, cT3, or cT4 including inflammatory disease. Metastatic disease is excluded. All patients will be treated with 3 cycles Docetaxel and 3 cycles FEC.MedDRA version: 14.1Level: PTClassification code 10006201Term: Breast cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10021974Term: Inflammatory breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006202Term: Breast cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006200Term: Breast cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-006381-29-DEniversitätsmedizin Mainz200
尚未招募
1 期
Phase l/ll study of adjuvant chemotherapy (TC therapy) after concurrent chemoradiation in cervical cancer with lymphadenopathyCervical cancer with lymphadenopathyJPRN-UMIN000004897The University of Tokushima Graduate School30
已完成
不适用
Adjuvant chemotherapy combined with docetaxel and cyclophosphamide for Japanese breast cancer patients without lymph node metastasis or with three and under lymph node metastasis.Breast cancerJPRN-UMIN000002310Gunma Breast Cancer Research Group 2 surgery90
招募中
2 期
Feasibility study of adjuvant chemotherapy with TS-1 followed by DCS (DTX+CDDP+S-1) for stage III gastric cancerGastric CancerJPRN-UMIN000012785Shimane University Hospital30
进行中（未招募）
不适用
Induction chemotherapy with docetaxel and cisplatin followed by radiotherapy concomitant with cetuximab for locally advanced stage III non-small cell lung cancer- amulticentre, open label non-randomised phase II trial - SatellitPatient with locally advanced stage III non-small cell lung cancer.EUCTR2005-003867-21-SESahlgrenska University Hospital75